Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1968 Nov;3(9):901–909.

Natural antibodies to procaine amide

A S Russell, M Ziff
PMCID: PMC1579007  PMID: 5751875

Abstract

A method has been developed for assay of antibody reactive with procaine amide (PrA) which utilizes sheep red blood cells coupled with diazotized PrA. Antibody of the IgM class was found in 19–50% of the populations tested. These included patients with systemic lupus erythematosus (SLE), rheumatoid arthritis, juvenile rheumatoid arthritis, miscellaneous diseases, cardiac patients receiving PrA and normal adults. Only 6% of patients with PrA-induced systemic lupus erythematosus had antibody. Antibody was not found in neonatal children, nor in rabbits and hamsters, but was found in 78% of normal dogs.

Immunization of rabbits with a PrA–bovine serum albumin complex induced anti-PrA antibody in high titre. Antibody titres in these rabbits and in man could be abolished by addition of PrA to the titration system.

Seventy-four per cent of unselected patients receiving PrA for over 2 months were found to have antinuclear antibody in significant titre. It is suggested that the high incidence of antinuclear antibody and SLE-like disease in patients receiving PrA may be related to the wide occurrence of natural antibody to PrA.

Full text

PDF
901

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón-Segovia D., Wakim K. G., Worthington J. W., Ward L. E. Clinical and experimental studies on the hydralazine syndrome and its relationship to systemic lupus erythematosus. Medicine (Baltimore) 1967 Jan;46(1):1–33. doi: 10.1097/00005792-196701000-00001. [DOI] [PubMed] [Google Scholar]
  2. Breckenridge A., Dollery C. T., Worlledge S. M., Holborow E. J., Johnson G. D. Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet. 1967 Dec 16;2(7529):1265–1267. doi: 10.1016/s0140-6736(67)90387-x. [DOI] [PubMed] [Google Scholar]
  3. COLMAN R. W., STURGILL B. C. LUPUS-LIKE SYNDROME INDUCED BY PROCAINE AMIDE: ASSOCIATION WITH ANTI-DNA ANTIBODY. Arch Intern Med. 1965 Feb;115:214–216. doi: 10.1001/archinte.1965.03860140094021. [DOI] [PubMed] [Google Scholar]
  4. Cannat A., Seligmann M. Possible induction of antinuclear antibodies by isoniazid. Lancet. 1966 Jan 22;1(7430):185–187. doi: 10.1016/s0140-6736(66)90704-5. [DOI] [PubMed] [Google Scholar]
  5. Carabia A. G., Fortney T. G., Jr Case report: lupus-like syndrome with positive Hargrave phenomenon induced by pronestyl therapy: analysis of the test. J Tenn Med Assoc. 1965 Sep;58(9):287–289. [PubMed] [Google Scholar]
  6. Compton-Smith R. N., Fawcett J. W. Systemic lupus erythematosus associated with procainamide. Br J Clin Pract. 1967 May;21(5):248–251. [PubMed] [Google Scholar]
  7. DOMZ C. A., McNAMARA D. H., HOLZAPFEL H. F. Tetracycline provocation in lupus erythematosus. Ann Intern Med. 1959 May;50(5):1217–1226. doi: 10.7326/0003-4819-50-5-1217. [DOI] [PubMed] [Google Scholar]
  8. DUSTAN H. P., TAYLOR R. D., CORCORAN A. C. Rheumatic and febrile syndrome during prolonged hydralazine treatment. J Am Med Assoc. 1954 Jan 2;154(1):23–29. doi: 10.1001/jama.1954.02940350025006. [DOI] [PubMed] [Google Scholar]
  9. Fakhro A. M., Ritchie R. F., Lown B. Lupus-like syndrome induced by procainamide. Am J Cardiol. 1967 Sep;20(3):367–373. doi: 10.1016/0002-9149(67)90060-4. [DOI] [PubMed] [Google Scholar]
  10. GOLD S. Role of sulphonamides and penicillin in the pathogenesis of systemic lupus erythematosus. Lancet. 1951 Feb 3;1(6649):268–272. doi: 10.1016/s0140-6736(51)93319-3. [DOI] [PubMed] [Google Scholar]
  11. HAHN A. L. SYSTEMIC LUPUS ERYTHEMATOSUS ASSOCIATED WITH PROCAINAMIDE THERAPY. Mo Med. 1964 Jan;61:19–PASSIM. [PubMed] [Google Scholar]
  12. HEINE W. I., FRIEDMAN H. Hydralazine lupus syndrome associated with a possible antihydralazine antibody. JAMA. 1962 Nov 17;182:726–729. [PubMed] [Google Scholar]
  13. Hope J. G., Provan G. C. Hematological effects of alpha-methyldopa. Scott Med J. 1967 Jun;12(6):229–231. doi: 10.1177/003693306701200605. [DOI] [PubMed] [Google Scholar]
  14. JACOBS J. C. SYSTEMIC LUPUS ERYTHEMATOSUS IN CHILDHOOD. REPORT OF THIRTY-FIVE CASES, WITH DISCUSSION OF SEVEN APPARENTLY INDUCED BY ANTICONVULSANT MEDICATION, AND OF PROGNOSIS AND TREATMENT. Pediatrics. 1963 Aug;32:257–264. [PubMed] [Google Scholar]
  15. KAPLAN J. M., WACHTEL H. L., CZARNECKI S. W., SAMPSON J. J. LUPUS-LIKE ILLNESS PRECIPITATED BY PROCAINAMIDE HYDROCHLORIDE. JAMA. 1965 May 10;192:444–447. doi: 10.1001/jama.1965.03080190010003. [DOI] [PubMed] [Google Scholar]
  16. LADD A. T. Procainamide-induced lupus erythematosus. N Engl J Med. 1962 Dec 27;267:1357–1358. doi: 10.1056/NEJM196212272672608. [DOI] [PubMed] [Google Scholar]
  17. LEWIS R. M., SCHWARTZ R., HENRY W. B., Jr CANINE SYSTEMIC LUPUS ERYTHEMATOSUS. Blood. 1965 Feb;25:143–160. [PubMed] [Google Scholar]
  18. LINDQVIST T. Lupus erythematosus disseminatus after administration of mesantoin; report of two cases. Acta Med Scand. 1957 Aug 13;158(2):131–138. doi: 10.1111/j.0954-6820.1957.tb15754.x. [DOI] [PubMed] [Google Scholar]
  19. LoBuglio A. F., Jandl J. H. The nature of the alpha-methyldopa red-cell antibody. N Engl J Med. 1967 Mar 23;276(12):658–665. doi: 10.1056/NEJM196703232761203. [DOI] [PubMed] [Google Scholar]
  20. MORROW J. D., SCHROEDER H. A., PERRY H. M., Jr Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. 1953 Dec;8(6):829–839. doi: 10.1161/01.cir.8.6.829. [DOI] [PubMed] [Google Scholar]
  21. OGRYZLO M. A. The L.E. (lupus erythematosus) cell reaction. Can Med Assoc J. 1956 Dec 15;75(12):980–993. [PMC free article] [PubMed] [Google Scholar]
  22. PERRY H. M., Jr, SCHROEDER H. A. Syndrome simulating collagen disease caused by hydralazine (Apresoline). J Am Med Assoc. 1954 Feb 20;154(8):670–673. doi: 10.1001/jama.1954.02940420032009. [DOI] [PubMed] [Google Scholar]
  23. Paine R. Procainamide hydrochloride and lupus erythematosus. JAMA. 1965 Oct 4;194(1):23–26. [PubMed] [Google Scholar]
  24. Prockop L. D. Myotonia, procaine amide, and lupus-like syndrome. Arch Neurol. 1966 Mar;14(3):326–330. doi: 10.1001/archneur.1966.00470090098014. [DOI] [PubMed] [Google Scholar]
  25. RALLISON M. L., CARLISLE J. W., LEE R. E., Jr, VERNIER R. L., GOOD R. A. Lupus erythematosus and Stevens-Johnson syndrome. Occurrence as reactions to anticonvulsant medication. Am J Dis Child. 1961 Jun;101:725–738. doi: 10.1001/archpedi.1961.04020070039007. [DOI] [PubMed] [Google Scholar]
  26. RALLISON M. L., O'BRIEN J., GOOD R. A. Severe reactions to long-acting sulfonamides. Erythema multiforme exudativum and lupus erythematosus following administration of sulfamethoxypyridazine and sulfadimethoxine. Pediatrics. 1961 Dec;28:908–917. [PubMed] [Google Scholar]
  27. Rosin J. M. Vasculitis following procaine amide therapy. Am J Med. 1967 Apr;42(4):625–629. doi: 10.1016/0002-9343(67)90062-9. [DOI] [PubMed] [Google Scholar]
  28. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  29. STAVITSKY A. B. Micromethods for the study of proteins and antibodies. I. Procedure and general applications of hemagglutination and hemagglutination-inhibition reactions with tannic acid and protein-treated red blood cells. J Immunol. 1954 May;72(5):360–367. [PubMed] [Google Scholar]
  30. Sanford H. S., Michaelson A. K., Halpern M. M. Procainamide induced lupus erythematosus syndrome. Dis Chest. 1967 Feb;51(2):172–176. doi: 10.1378/chest.51.2.172. [DOI] [PubMed] [Google Scholar]
  31. Sherman J. D., Love D. E., Harrington J. F. Anemia, positive lupus and rheumatoid factors with methyldopa. A report of three cases. Arch Intern Med. 1967 Sep;120(3):321–326. [PubMed] [Google Scholar]
  32. WALSH J. R., ZIMMERMAN H. J. The demonstration of the L.E. phenomenon in patients with penicillin hypersensitivity. Blood. 1953 Jan;8(1):65–71. [PubMed] [Google Scholar]
  33. WILSKE K. R., SHALIT I. E., WILLKENS R. F., DECKER J. L. FINDINGS SUGGESTIVE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN SUBJECTS ON CHRONIC ANTICONVULSANT THERAPY. Arthritis Rheum. 1965 Apr;8:260–266. doi: 10.1002/art.1780080209. [DOI] [PubMed] [Google Scholar]
  34. Weir D. M. The immunologicial consequences of cell death. Lancet. 1967 Nov 18;2(7525):1071–1073. doi: 10.1016/s0140-6736(67)90342-x. [DOI] [PubMed] [Google Scholar]
  35. Worlledge S. M., Carstairs K. C., Dacie J. V. Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy. Lancet. 1966 Jul 16;2(7455):135–139. doi: 10.1016/s0140-6736(66)92423-8. [DOI] [PubMed] [Google Scholar]
  36. ZINGALE S. B., MINZER L., ROSENBERG B., LEE S. L. Drug induced lupus-like syndrome. Clinical and laboratory syndrome similar to systemic lupus erythematosus following antituberculous therapy: report of a case. Arch Intern Med. 1963 Jul;112:63–66. doi: 10.1001/archinte.1963.03860010109012. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES